My Bibliography

select

Nesbitt NM, Malone LE, Liu Z, Jares A, Gnatenko DV, Ma Y, Zhu W, Bahou WF. Divergent erythroid megakaryocyte fates in Blvrb-deficient mice establish non-overlapping cytoprotective functions during stress hematopoiesis. Free Radic Biol Med. 2021 Feb 20;164:164-174. doi: 10.1016/j.freeradbiomed.2020.12.015. Epub 2020 Dec 24. PubMed PMID: 33359909; PubMed Central PMCID: PMC8311568.

select

Pinz KG, Yakaboski E, Jares A, Liu H, Firor AE, Chen KH, Wada M, Salman H, Tse W, Hagag N, Lan F, Leung EL, Jiang X, Ma Y. Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells. Oncotarget. 2017 Dec 22;8(68):112783-112796. doi: 10.18632/oncotarget.22626. eCollection 2017 Dec 22. PubMed PMID: 29348865; PubMed Central PMCID: PMC5762550.

select

Chen KH, Wada M, Pinz KG, Liu H, Lin KW, Jares A, Firor AE, Shuai X, Salman H, Golightly M, Lan F, Senzel L, Leung EL, Jiang X, Ma Y. Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor. Leukemia. 2017 Oct;31(10):2151-2160. doi: 10.1038/leu.2017.8. Epub 2017 Jan 12. PubMed PMID: 28074066; PubMed Central PMCID: PMC5629371.

select

Chen KH, Wada M, Firor AE, Pinz KG, Jares A, Liu H, Salman H, Golightly M, Lan F, Jiang X, Ma Y. Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies. Oncotarget. 2016 Aug 30;7(35):56219-56232. doi: 10.18632/oncotarget.11019. PubMed PMID: 27494836; PubMed Central PMCID: PMC5302909.

select

Pinz K, Liu H, Golightly M, Jares A, Lan F, Zieve GW, Hagag N, Schuster M, Firor AE, Jiang X, Ma Y. Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells. Leukemia. 2016 Mar;30(3):701-7. doi: 10.1038/leu.2015.311. Epub 2015 Nov 3. PubMed PMID: 26526988.

select

Firor AE, Jares A, Ma Y. From humble beginnings to success in the clinic: Chimeric antigen receptor-modified T-cells and implications for immunotherapy. Exp Biol Med (Maywood). 2015 Aug;240(8):1087-98. doi: 10.1177/1535370215584936. Epub 2015 May 7. Review. PubMed PMID: 25956686; PubMed Central PMCID: PMC4935283.

select

Liao W, Huang N, Yu J, Jares A, Yang J, Zieve G, Avila C, Jiang X, Zhang XB, Ma Y. Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4. Stem Cells Transl Med. 2015 Jul;4(7):755-63. doi: 10.5966/sctm.2014-0289. Epub 2015 May 13. PubMed PMID: 25972144; PubMed Central PMCID: PMC4479625.

select

Wu C, Hong SG, Winkler T, Spencer DM, Jares A, Ichwan B, Nicolae A, Guo V, Larochelle A, Dunbar CE. Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies. Mol Ther Methods Clin Dev. 2014;1:14053. doi: 10.1038/mtm.2014.53. eCollection 2014. PubMed PMID: 26052521; PubMed Central PMCID: PMC4448736.

select

Yakaboski E, Jares A, Ma Y. Stem cell gene SALL4 in aggressive hepatocellular carcinoma: a cancer stem cell-specific target?. Hepatology. 2014 Jul;60(1):419-421. doi: 10.1002/hep.26956. Epub 2014 May 27. PubMed PMID: 24327209; PubMed Central PMCID: PMC4290879.

select

Firor AE, Jares A. Nuclear localization of SALL4: a stemness transcription factor. Cell Cycle. 2014;13(10):1522-3. doi: 10.4161/cc.28901. Epub 2014 Apr 22. PubMed PMID: 24755779; PubMed Central PMCID: PMC4050156.

select

Wu C, Li B, Lu R, Koelle SJ, Yang Y, Jares A, Krouse AE, Metzger M, Liang F, Loré K, Wu CO, Donahue RE, Chen ISY, Weissman I, Dunbar CE. Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell. 2014 Apr 3;14(4):486-499. doi: 10.1016/j.stem.2014.01.020. PubMed PMID: 24702997; PubMed Central PMCID: PMC3979461.

select

Wu C, Jares A, Winkler T, Xie J, Metais JY, Dunbar CE. High efficiency restriction enzyme-free linear amplification-mediated polymerase chain reaction approach for tracking lentiviral integration sites does not abrogate retrieval bias. Hum Gene Ther. 2013 Jan;24(1):38-47. doi: 10.1089/hum.2012.082. Epub 2012 Oct 26. PubMed PMID: 22992116; PubMed Central PMCID: PMC3555095.